Predictions
Stratec SE
Start price
Target price
Perf. (%)
€116.60
03.03.21
03.03.21
€165.00
03.10.22
03.10.22
3.43%
06.04.22
06.04.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€28.30
27.11.21
27.11.21
€28.00
27.11.22
27.11.22
-44.88%
30.03.22
30.03.22
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.015
20.02.22
20.02.22
€7.50
20.03.22
20.03.22
61900.00%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€3.04
20.02.22
20.02.22
€4.00
20.03.22
20.03.22
-11.39%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€81.03
15.03.22
15.03.22
-
15.03.23
15.03.23
-14.84%
20.03.22
20.03.22
Could be worthwhile Investment >10% per year
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€20.53
14.03.22
14.03.22
€14.00
14.03.23
14.03.23
3.70%
16.03.22
16.03.22
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€30.25
13.10.21
13.10.21
€34.00
30.07.22
30.07.22
-32.13%
14.03.22
14.03.22
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.39
30.01.22
30.01.22
€4.00
30.01.23
30.01.23
-10.83%
14.03.22
14.03.22
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€4.66
12.07.21
12.07.21
-
12.07.22
12.07.22
48.95%
13.03.22
13.03.22
Vivani Medical Inc.
Start price
Target price
Perf. (%)
€26.55
10.03.21
10.03.21
-
10.03.22
10.03.22
-86.89%
11.03.22
11.03.22
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€18.30
09.02.22
09.02.22
€20.00
09.03.22
09.03.22
-7.10%
10.03.22
10.03.22
Could be worthwhile Investment >10% per year
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€11.37
17.06.21
17.06.21
€18.00
09.03.22
09.03.22
95.60%
10.03.22
10.03.22
Could be very worthwhile Investment >20% year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€61.80
08.03.21
08.03.21
-
08.03.22
08.03.22
-21.91%
09.03.22
09.03.22
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
05.09.21
05.09.21
-
05.09.22
05.09.22
-47.79%
07.03.22
07.03.22
Probably not worthwhile Investment
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€2.31
20.02.22
20.02.22
-
20.02.23
20.02.23
-6.49%
05.03.22
05.03.22
Risky Investment
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€29.39
20.02.22
20.02.22
-
20.02.23
20.02.23
-0.65%
05.03.22
05.03.22
Could be very worthwhile Investment >20% year
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.03
22.02.22
22.02.22
€1.00
22.02.23
22.02.23
-25.24%
05.03.22
05.03.22
Could be worthwhile Investment >10% per year
Capable Management
Bad culture
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€13.28
14.12.21
14.12.21
€0.000
14.12.22
14.12.22
-99.89%
20.02.22
20.02.22
Could be worthwhile Investment >10% per year
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€2.53
06.02.22
06.02.22
-
06.02.23
06.02.23
-8.76%
20.02.22
20.02.22
Could be very worthwhile Investment >20% year
Poxel S.A.
Start price
Target price
Perf. (%)
€4.07
15.02.22
15.02.22
€5.00
15.03.22
15.03.22
-25.36%
20.02.22
20.02.22
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.02
16.02.22
16.02.22
-
16.02.23
16.02.23
-10.26%
19.02.22
19.02.22
Could be worthwhile Investment >10% per year